Explore how PBMs negotiate drug costs, serve as middlemen between insurers and drug makers, and why they're vital yet controversial in healthcare.

It’s not just drugmakers reshaping the pharmaceutical sector; distributors are rapidly transforming, too. While most investors and policymakers focus on rising prescription drug prices or ...